The impact, understanding of test-results, and satisfaction among participating couples in a preconception cystic fibrosis (CF) carrier screening project were assessed 6 months after testing. Questionnaire data were obtained from 17/18 identified carriers, 15 partners of carriers with negative test results, and 794 (73%) other participants. None of the carriers changed their reproductive plans because of their test results. Eight participants were worried about their results, including four carriers. Those who attended a general practitioner (GP) consultation for pretest education were less worried than those who attended an educational session. Seven carriers felt less healthy. Predictors of a correct understanding of test results (correct...
To determine the attitudes of potential providers (general practitioners and Community Health Servic...
OBJECTIVE: This qualitative study aimed to explore possibilities and barriers in the implementation ...
Population carrier screening for cystic fibrosis (CF) was offered to all patients aged 16–45 in one ...
Contains fulltext : 57426.pdf (publisher's version ) (Open Access)The aim of this ...
Objective. To investigate the desirability and feasibility of preconception cystic fibrosis (CF) car...
This qualitative study explores the experiences of cystic fibrosis (CF) carrier couples, prospective...
This qualitative study explores the experiences of cystic fibrosis (CF) carrier couples, prospective...
This qualitative study explores the experiences of cystic fibrosis (CF) carrier couples, prospective...
This qualitative study explores the experiences of cystic fibrosis (CF) carrier couples, prospective...
This qualitative study explores the experiences of cystic fibrosis (CF) carrier couples, prospective...
Objective: To investigate the feasibility and acceptability of different modes of offering preconcep...
BACKGROUND: Since the identification of the cystic fibrosis (CF) gene, large-scale CF carrier screen...
To determine the attitudes of potential providers (general practitioners and Community Health Servic...
This paper explores determinants of the intention to participate or not and of actual participation ...
This paper explores determinants of the intention to participate or not and of actual participation ...
To determine the attitudes of potential providers (general practitioners and Community Health Servic...
OBJECTIVE: This qualitative study aimed to explore possibilities and barriers in the implementation ...
Population carrier screening for cystic fibrosis (CF) was offered to all patients aged 16–45 in one ...
Contains fulltext : 57426.pdf (publisher's version ) (Open Access)The aim of this ...
Objective. To investigate the desirability and feasibility of preconception cystic fibrosis (CF) car...
This qualitative study explores the experiences of cystic fibrosis (CF) carrier couples, prospective...
This qualitative study explores the experiences of cystic fibrosis (CF) carrier couples, prospective...
This qualitative study explores the experiences of cystic fibrosis (CF) carrier couples, prospective...
This qualitative study explores the experiences of cystic fibrosis (CF) carrier couples, prospective...
This qualitative study explores the experiences of cystic fibrosis (CF) carrier couples, prospective...
Objective: To investigate the feasibility and acceptability of different modes of offering preconcep...
BACKGROUND: Since the identification of the cystic fibrosis (CF) gene, large-scale CF carrier screen...
To determine the attitudes of potential providers (general practitioners and Community Health Servic...
This paper explores determinants of the intention to participate or not and of actual participation ...
This paper explores determinants of the intention to participate or not and of actual participation ...
To determine the attitudes of potential providers (general practitioners and Community Health Servic...
OBJECTIVE: This qualitative study aimed to explore possibilities and barriers in the implementation ...
Population carrier screening for cystic fibrosis (CF) was offered to all patients aged 16–45 in one ...